However, CCL2 deficiency or CCL2 antibody treatment enhances damage and impedes repair of the alveolar epithelium after infection with a sublethal dose of influenza A virus or mouse-adapted human influenza virus (Dessing et al., 2007; Narasaraju et al., 2010). This evidence concerns the gene CCL2 and infection.